Testing intermittent fasting in prostate cancer patients on hormone therapy

This pilot study is exploring whether intermittent fasting — a pattern where you eat within a set window of time each day and fast for the rest — may be helpful or practical for men with prostate cancer who are receiving androgen deprivation therapy (a hormone treatment). Researchers want to see if this eating pattern is something patients can realistically follow, and whether it might help with side effects or outcomes during cancer treatment. The study will also offer an optional plant-based diet approach for interested participants.

Men receiving hormone therapy for prostate cancer often experience difficult side effects like weight gain, loss of muscle, and metabolic changes. This study exists to explore whether intermittent fasting might be a practical way to help manage these effects and improve overall health during treatment.